[title] | [date] | [link] | [market] | [doc type] | [stock code] | [stock name] |
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section | 03/01/2022 07:42 | Link | SEHK | htm | 00425 | MINTH GROUP |
OFFER TO PURCHASE THE OUTSTANDING 5.5% SENIOR NOTES DUE 2022 (ISIN: XS1513700127, COMMON CODE: 151370012, STOCK CODE: 5340) | 03/01/2022 07:40 | Link | SEHK | 00884 | CIFI HOLD GP | |
DISCLOSEABLE TRANSACTIONS - ADDENDUMS OF THE HEADS OF AGREEMENTS IN RELATION TO THE PROPOSED TRANSACTIONS | 03/01/2022 07:37 | Link | SEHK | 00866 | CHINA QINFA | |
List of Directors and their Role and Function | 03/01/2022 07:37 | Link | SEHK | 02378 | PRU | |
VOLUNTARY ANNOUNCEMENT - LATEST DEVELOPMENT ON COOPERATING WITH THE ANTI-EPIDEMIC MEASURES OF THE PRC LOCAL GOVERNMENT | 03/01/2022 07:30 | Link | SEHK | 02313 | SHENZHOU INTL | |
Transaction in own shares | 03/01/2022 07:13 | Link | SEHK | 00005 | HSBC HOLDINGS | |
CLARIFICATION ANNOUNCEMENT | 03/01/2022 07:12 | Link | SEHK | 00318 | VONGROUP | |
Voting Rights and Capital | 03/01/2022 07:10 | Link | SEHK | 00005 | HSBC HOLDINGS | |
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG | 03/01/2022 07:05 | Link | SEHK | 06166 | CHINA VAST | |
Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities | 03/01/2022 06:26 | Link | SEHK | 02198 | CHINA SANJIANG | |
DISCLOSEABLE TRANSACTION - FUNDRAISING OF XUANZHU BIOPHARMACEUTICAL TECHNOLOGY CO., LTD. | 03/01/2022 06:06 | Link | SEHK | 00460 | SIHUAN PHARM | |
Announcement in Response to Shanghai Stock Exchange's Regulatory Letter in Relation to the Information Disclosure in the Third Quarterly Report for 2021 | 02/01/2022 19:45 | Link | SEHK | 02727 | SH ELECTRIC | |
VOLUNTARY ANNOUNCEMENT ENROLLMENT OF FIRST PATIENT AND INITIATION OF PHASE III CLINICAL TRIAL OF KX-826 FOR TREATMENT OF AGA | 02/01/2022 19:31 | Link | SEHK | 09939 | KINTOR PHARMA-B | |
PARTIAL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZATION ACTIONS AND END OF STABILIZATION PERIOD | 02/01/2022 19:24 | Link | SEHK | 06821 | ASYMCHEM | |
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 02/01/2022 19:14 | Link | SEHK | 00522 | ASM PACIFIC | |
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2021 | 02/01/2022 19:03 | Link | SEHK | 01495 | JIYI HOLDINGS | |
QUARTERLY UPDATE ON RESUMPTION PROGRESS | 02/01/2022 18:54 | Link | SEHK | 00263 | GT GROUP HLDG | |
List of Directors and their Roles and Functions | 02/01/2022 18:34 | Link | SEHK | 00950 | LEE'S PHARM | |
TERMINATION OF THE ORIGINAL PROCEEDS-INVESTED PROJECT AND CHANGE OF THE USE OF PART OF THE PROCEEDS AND CAPITAL INCREASE IN A WHOLLY-OWNED SUBSIDIARY | 02/01/2022 18:31 | Link | SEHK | 02218 | ANDRE JUICE | |
Terms of Reference of the Nomination Committee | 02/01/2022 18:31 | Link | SEHK | 00950 | LEE'S PHARM |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Minth Group Limited published this content on 03 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 January 2022 23:48:06 UTC.